News & Events

Recent News View All News

Jul 16, 2026 7:30am EDT

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Jul 10, 2026 4:05pm EDT

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings